Date Announcement
22/05/2020 General Meeting – May 2020
22/05/2020 Results of May 2020 General Meeting
15/05/2020 COMPANY UPDATE AND EXTENSION OF VOLUNTARY SUSPENSION
14/05/2020 AMENDMENT TO NOTICE OF GENERAL MEETING
11/05/2020 Cellmid Limited (ASX: CDY) – Suspension from Official Quotation
07/05/2020 Cellmid Limited (ASX: CDY) – Trading Halt
07/05/2020 Pause in Trading
04/05/2020 Appendix 2A – Application for quotation of +securities
04/05/2020 CELLMID SHARE PURCHASE PLAN COMPLETED
30/04/2020 CELLMID’S ALOPECIA PATENT ALLOWED IN AUSTRALIA AND JAPAN
27/04/2020 CELLMID APPENDIX 4C – Q3 FY2020 BUSINESS ACTIVITY
22/04/2020 INDEPENDENT TEST RESULTS FOR THE WONDFO SARS-CoV-2 TEST
22/04/2020 Notice of May 2020 General Meeting
16/04/2020 Share Purchase Plan
14/04/2020 Appendix 2A – Application for quotation of +securities
14/04/2020 CELLMID’S SHIPMENT OF SARS-CoV-2 TESTS RECEIVED
14/04/2020 Market Release – Pause in Trading
08/04/2020 An offer of +securities under a +securities purchase plan
07/04/2020 Cellmid Limited (ASX: CDY) – Reinstatement to Official Quotation
07/04/2020 CELLMID SHARE PLACEMENT RAISES $6 MILLION
07/04/2020 Total number of +securities proposed to be issued for a placement or other type of issue
06/04/2020 Cellmid Limited (ASX: CDY) – Suspension from Official Quotation
01/04/2020 Cellmid Limited (ASX: CDY) – Trading Halt
28/03/2020 Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
28/03/2020 Market Update on COVID-19
28/03/2020 Reinstatement to Official Quotation
06/03/2020 New Distribution channels to drive revenue growth from 2H FY2020
04/03/2020 Appendix 3G – Notification of issue, conversion or payment up of equity +securities
27/02/2020 1H FY2020 Financial Results
04/02/2020 Cellmid’s evolis patent to be granted in China
29/01/2020 Cellmid Limited notes to the Appendix 4C
06/01/2020 Key Midkine Antibody Patents granted in the US and Europe
30/05/2020 Notice of May 2020 General Meeting

 

 

Shop évolis®

Join our CORONAVIRUS Antibody study

Diagnosed with CORONAVIRUS?
We are looking for volunteers to help us study the body’s long term immune response to infection.
>> Sign up to express your interest